Utility of endoscopic pressure study integrated system for gastroesophageal reflux disease after endoscopic antireflux therapy
Digestive Endoscopy · 2025
DOI: 10.1111/den.14989 ↗Kurz gefasst
Fachartikel in der Zeitschrift Digestive Endoscopy, 2025. Verfasst von Kazuki Yamamoto und 11 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Endoscopy, Digestive System. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
Objectives
The endoscopic pressure study integrated system (EPSIS) measures intragastric pressure (IGP) during esophagogastroduodenoscopy. Previous research demonstrated that EPSIS correlates with the 24‐h impedance‐pH (MII‐pH) test and shows lower maximum IGP (IGP‐Max) and a flatter waveform gradient in gastroesophageal reflux disease (GERD) patients, attributed to lower esophageal sphincter dysfunction. Although endoscopic antireflux therapy (EARTh) is effective for GERD, the MII‐pH monitoring, the gold standard for assessing treatment outcomes, requires hospitalization and can be a burden. EPSIS offers a noninvasive alternative for evaluating post‐EARTh outcomes. This study aimed to assess EPSIS as an additional diagnostic tool in this context.
Methods
We conducted a retrospective analysis of GERD patients who underwent EARTh and were subsequently assessed using EPSIS within 6 months, from May 2018 to April 2024. Changes in IGP parameters, including IGP‐Max and waveform gradient, were analyzed pre‐ and post‐EARTh. Additionally, the study examined Hill's Classification following EARTh.
Results
Out of 39 patients assessed with EPSIS before and after EARTh, the average age was 55 years (standard deviation [SD] 16.7), with 64.1% male. Postoperative IGP‐Max increased from 15.2 mmHg to 18.0 mmHg ( P = 0.004), and the pressure gradient improved from 0.16 mmHg/s to 0.28 mmHg/s ( P < 0.001). Hill's Classification improved significantly from a mean of 2.2 (SD 0.7) to 1.1 (SD 0.3) ( P < 0.001).
Conclusion
This study indicates that EPSIS is a reliable diagnostic tool for evaluating the effects of EARTh and holds potential as a supplementary tool for assessing GERD treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
- Department of Gastroenterology, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
- Endoscopy Unit, Mongolia Japan Hospital, Ulaanbaatar, Mongolia.
ORCID-Profile: Kazuki Yamamoto, Ippei Tanaka, Hidenori Tanaka, Mayo Tanabe, Satoshi Abiko, Yuto Shimamura
Zitieren
APA
Yamamoto, K., Inoue, H., Tanaka, I., Ushikubo, K., Iwasaki, M., Nishikawa, Y., Tanaka, H., Tanabe, M., Abiko, S., Gantuya, B., Onimaru, M., & Shimamura, Y. (2025). Utility of endoscopic pressure study integrated system for gastroesophageal reflux disease after endoscopic antireflux therapy. Digestive Endoscopy. https://doi.org/10.1111/den.14989
Vancouver
Yamamoto K, Inoue H, Tanaka I, Ushikubo K, Iwasaki M, Nishikawa Y, et al. Utility of endoscopic pressure study integrated system for gastroesophageal reflux disease after endoscopic antireflux therapy. Digestive Endoscopy. 2025. doi:10.1111/den.14989
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Kazuki and Inoue, Haruhiro and Tanaka, Ippei and Ushikubo, Kei and Iwasaki, Miyuki and Nishikawa, Yohei and Tanaka, Hidenori and Tanabe, Mayo and Abiko, Satoshi and Gantuya, Boldbaatar and Onimaru, Manabu and Shimamura, Yuto},
title = {Utility of endoscopic pressure study integrated system for gastroesophageal reflux disease after endoscopic antireflux therapy},
journal = {Digestive Endoscopy},
year = {2025},
doi = {10.1111/den.14989}
}
EUVIMED